Comprehensive Laboratory & Specimen Collection Services

Integral Care seeks a qualified laboratory services provider to deliver comprehensive clinical laboratory testing and on‑site specimen collection services that support Integral Care’s mission to expand access to care, improve client outcomes, and promote stabilization for individuals receiving behavioral health services across the community, as more particularly described in this RFP (collectively, the “Services”). The selected vendor will provide timely, reliable laboratory testing that supports diagnostic evaluation, medication management, crisis stabilization, and ongoing treatment across all Integral Care programs.

Required laboratory services include, but are not limited to:

·         Routine blood panels and general laboratory diagnostics

·         Medication monitoring related to psychotropic medications

·         Metabolic monitoring

·         Hematology testing

·         Endocrine screening

·         Infectious disease testing

·         Urine testing and urinalysis

·         Toxicology screening

·         Drug testing for substance use treatment programs

·         Sexually transmitted infection (STI) testing

·         HIV and Hepatitis screening

·         Tuberculosis (TB) testing

·         Other laboratory diagnostics necessary to support behavioral health treatment and clinical decision‑making

Based on historical testing data, the most frequently ordered laboratory tests include:

·         Complete Blood Count (CBC)

·         Hemoglobin A1C testing

·         Lipid panels

·         Comprehensive metabolic panels (CMP)

·         Thyroid testing (TSH/Free T4)

·         Therapeutic drug monitoring (Lithium, Valproic Acid, Clozapine)

·         Urine toxicology screening panels

·         Infectious disease screening (HIV, Hepatitis)

Proposers (defined below) should demonstrate strong operational capability supporting these high-volume tests.

Integral Care seeks laboratory services that support routine testing turnaround times and offer flexibility for expedited processing when clinically indicated. Proposers should describe available stat, rapid, or other expedited testing options and associated turnaround times, if applicable